Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | PRF1 | P14222 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.33 |
| ▸ | ESRRB | O95718 | 1/20 | 0.33 |
| ▸ | ESRRA | P11474 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546597 | 0.97 | STS (0.37) | STSPGRADORA2AADRA2CCHEK1 | |
| SCHEMBL21546807 | 0.93 | STS (0.38) | STSPGRMAP4K4ADRA2CCHEK1 | |
| SCHEMBL21546632 | 0.93 | PGR (0.40) | PGRMAP4K4ADORA2AADRA2CCHEK1 | |
| SCHEMBL22760921 | 0.92 | PGR (0.38) | PGRMAP4K4ADORA2AADRA2CCHEK1 | |
| SCHEMBL21414146 | 0.92 | STS (0.38) | STS | |
| SCHEMBL21546912 | 0.92 | ADORA2A (0.38) | PGRADORA2AADRA2CBRD4LRRK2 | |
| SCHEMBL22761140 | 0.91 | STS (0.38) | STSPGRMAP4K4ADORA2AADRA2C | |
| SCHEMBL22760659 | 0.91 | NR3C1 (0.39) | ADORA2AADRA2CENPP1CLK4ALDH1A3 | |
| SCHEMBL21546590 | 0.91 | STS (0.37) | STSPGRADORA2AADRA2CCHEK1 | |
| SCHEMBL21546594 | 0.90 | STS (0.37) | STSPGRADORA2AADRA2CCHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981930-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| US-20200385399-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-10 | — | — | US | disclosed |
| EP-3478793-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981930-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OR51E2, EPCAM | STS 2957/4885PGR 3398/4885MAP4K4 2642/4885 |
| US-20200385399-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OR51E2, EPCAM | STS 2957/4885PGR 3398/4885MAP4K4 2642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.